Home › Sclerosing Cholangitis › California
Pag-aaral pangklinika para sa Sclerosing Cholangitis sa California
7 pag-aaral para sa Sclerosing Cholangitis ang naghahanap ng mga kalahok sa mga site sa California.
Mga Lungsod sa California
Opisyal na teksto ng pag-aaral (English)
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
- Southern California Research Center, Coronado
- University of California San Diego, La Jolla
- Keck Medicine of USC - USC Healthcare Center 1, Los Angeles
- at 6 pa
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07387549A-LiNK: Improving Outcomes in Autoimmune Liver Disease
- Stanford University, Palo Alto
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05750498Primary Sclerosing Cholangitis in Children
- Children's Hospital of Los Angeles, Los Angeles
Nagre-recruitObservasyonal na pag-aaral
Edad 2 hanggang 25 · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT04181138Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study
- Stanford University, Stanford
Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Peb 27, 2026 · NCT05912387A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
- University of California Davis, Sacramento
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 24, 2025 · NCT06699121Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.
- Stanford Clinic, Redwood City
- Stanford Clinic, Stanford
Nagre-recruitPhase 2
Edad 14 hanggang 75 · Lahat ng kasarian · Na-update Hun 13, 2025 · NCT05295680Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
- Sacramento Pediatric Gastroenterology, Sacramento
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
2 Weeks – 40 Years · Lahat ng kasarian · Na-update Nob 15, 2016 · NCT02137668Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.